Rokopol® X30 is a polyol-based aqueous solution. It exists in the form of a homogeneous, clear liquid. It is a crosslinking additive used in the production of flexible polyurethane foams.
It does not contain antioxidants. It has a hydroxyl value within the range of 1110-1140 mgKOH/g and dynamic viscosity within the range of 30-60 mPas at temp. 25°C.
Rokopol® X30 is a multifunctional crosslinking agent with a delayed response. Typical product dosage ranges from 1 to 1.5 parts by weight per 100 parts by weight of polyol. The optimal concentration will depend on the specifics of the formulation. The resulting HR (high resilience) and VE (viscoelastic) foam blocks show a much lower tendency to deform after seasoning.
Rokopol® X30 is soluble in water and aqueous-amine premixes. It should not be mixed with polyols, as this may result in the crystallization of the raw material.
Rokopol® X30 is used as an additive in the production of flexible polyurethane foams of the HR and VE types.
the product stabilizes the foam after production, reduces the "cold flow" effect,
accelerates and improves foam hardening,
results in a more even distribution of foam density,
improves dimensional stability and prevents deformation of the foam cross-section,
does not adversely affect other physical and mechanical parameters,
product not classified in accordance with the CLP/GHS Regulation,
PCC Rokita SA is one of the largest chemical companies in Poland as well as Central and Eastern Europe. Its activity includes the production of chloroalkali, polyether polyols, polyalkylene glycols and phosphorus derivatives.
All the above information related to the product are provided according to the best knowledge of the manufacturer and published in good faith. However, the manufacturer does not guarantee the information and contents of this document are complete and accurate, and shall not be liable for the results of using them. The user is obliged to verify and confirm the information and contents of this documentation on his/her own. The manufacturer reserves the right to change the content of this document at any time without stating reasons of such changes.
Subscribe to receive information about new products on the Product Portal and commercial information about the PCC Capital Group
By continuing to use our website, you are agreeing to the placement of cookies or similar technologies on your device for functional, statistical and marketing purposes. You can modify or withdraw your consent at any time in your browser settings. Learn more